Recalls & Warnings October 24, 2003 Court Closes the Doors on Company That Sold Weight Loss Supplement On October 24, 2003, the Federal Trade Commission (FTC)announced that Mark Nutritionals, Inc
GLP-1 prescriptions for weight-loss In a separate analysis between 2020 and 2023, one HealthVerity closed claims dataset had more than 1.5 million patients who had at least one prescription for tirzepatide or semaglutide
Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors
Everyone's results are a little different, depending on factors like your skin tone, hair color, and the severity of your KP
Its antibacterial activity reduces the risk of infection, while its antioxidant properties shield cells from oxidative stress
M., Kandemir, H., Shah, S